Romans 12:19
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$HTDS Some recovery.. 0.0006 ? -0.0001 Vol: 77,050,473 @02/09/21 2:55:35
$HTDS They drop it 98% on 10k shares on Open.. interesting BS - MM share GRAB ??
NeuroRx will host a conference call and webcast on February 9, 2021 at 9:00 a.m. EST to discuss study results. To participate in the conference call, dial +1 866-373-3402 (Toll-Free) or +1 201-689-7825 (International) Webcast can be accessed directly at https://lnkd.in/d4W6nzP
..from a tw--et
..maybe more good news came and they weren't ready to sort it out for the public.. FDA EUA is our next stop.. IMO
..you guys built a nice set of stairs today.. another flight tomorrow :)
$HTDS 0.0008+0.0005 (+275.00%) 2:53PM EST.
Hard to Treat Diseases Inc. (HTDS)
Other OTC
..heard a few people say they like the idea of the wrist-band breath alert thing.. the face breathing this is beyond uncomfortable.. ??
$HTDS mmmHHH?? 0.0006+0.0004 (+200.00%) 2:31PM EST
$HTDS mmmHHH?? 0.0006+0.0004 (+200.00%) 2:31PM EST
That's my post ..talked to them through twit--er after 2014 it was listed .. you can contact them direct..
$RLFTF DD "opinion" Post by DanG on Ya-h00 - I would not usually post, especially twice in one day, but it appears necessary.
First, I spoke to Brian Korb in Investor Relations at NeuroRx about an hour ago, right before Zaran posted. Basically Brian told us both that there is no conference call and any significant news will come via a press release.
In terms of all the speculation on the board I can only offer observations, as there is no firm data yet.
My experience investing in bio stocks is that rumors and long waits can cause fluctuations in price often unrelated to real news. So let's look at what we do know:
Trial results will be released this month.
The inhaled trial has begun.
Hiring continues in both NeuroRx and Relief, as well as companies responsible for production and distribution of Aviptadil.
The primary stockholder, GEM, has provided the means to fund Relief into 2022.
The merger between NeuroRx and BRPA is proceeding.
All available evidence indicates Aviptadil is effective and safe.
Conclusion:
There are no sure things but the evidence suggests there is good reason for optimism
..new people seem to be scrambling to get APYP saying .. it's not on my app.. where others reply.. get an account w/.. so I'm guessing new blood will be on-board soon to lock up shares like they did on those runners a week ago.. this could get interesting IMO
$HTDS WOW 0.0004+0.0002 (+100.00%) 10:21AM EST.
..as a few have pointed out.. moving ahead w/the inhaled trial was probably based on positive earlier results.. ??
$RLFTF (Related) NeuroRx will be hosting an update call tomorrow (8 Feb 2021) at 9:00am EST. Dial in to be announced.
https://www.linkedin.com/posts/jonathanjavitt_neurorx-will-be-hosting-an-update-call-tomorrow-activity-6764134026144956416-t_BN
Buying more !!! ..RLFTF may be more in the background but we're getting the higher %'s Worldwide
$RLFTF #TheMath
GENEVA, Switzerland and RADNOR, Pa. , Sept. 21, 2020 /PRNewswire/ --
RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) Relief Therapeutics and NeuroRx, Inc. today announced the completion of their partnership agreement for the commercialization of RLF-100â„¢(Aviptadil)
(Zyesami ) worldwide.
The two organizations have agreed to share all profits from sales of RLF-100 for all indications related to COVID-19 and potentially other respiratory indications on a global basis.
They have agreed that NeuroRx will lead commercialization in the United States , Canada , and Israel , while Relief will lead commercialization in Europe and the rest of the world.
Profits from sales will be allocated to Relief and NeuroRx on a 50/50 basis in the U.S., Canada and Israel , 85/15 (in favor of Relief) in Europe , and 80/20 (in favor of Relief) in all other territories.
http://www.prnewswire.com/news-releases/relief-and-neurorx-announce-partnership-for-global-commercialization-of-rlf-100-and-selection-of-commercial-partners-301134379.html
..needed a few extra buck for a play a week or two ago and sold my last thousand for $270.oo ... ugh!! x's 2 = uuuuGGGHHHH !!!!!
..the grey of it is denied is a strong word Dr. J also said they wanted more data and kept the application going.. IMO
..wide spread.. bid stayed low. ..maybe a good thing.. you may get more $$
my 1st of 3 will pick up at 0.0016's
Buying MORE !!!!
...yeah this Rattle-snake is coiled.. and Po'ed
..you can always sell during the mushroom cloud.. RE: My only fear is the possibility of a reverse split on the horizon.......
..it could be changed.. ;)
..I can't say.. I've been dumping winners and buying losers in this wild market the last few weeks so..
..?? no idea,, someone mentioned that on another board.. no clue on what type of company is moving in (there was assumptions made on the Patents) in the past.. But Marijuana would be nice as the Country is moving towards full legal IMO ..but will it matter.. many many new traders are coming in everyday.. volume should p/u across the board.
-edit:
oh I see.. NEW Company insiders.. not old..
$HTDS ..lots of green volume lines with s/p moving straight across.. ? could it be insiders getting their company packages.. ? 35 ml volume.. I suspect we're becoming a real company an are no longer just a shell. IMO
rrrrrrr
$MSTO mmh didn't think of that.. yeah they've been stockpiling Silver.. real silver ;)
$CYDY .. Reddit Rebellion Targeting The Short Mafia Next - https://insiderfinancial.com/reddit-rebellion-targeting-the-short-mafia-next/180939/
..from STPL on tw-t--r : You see them here too
https://www.ser-ag.com/en/resources/notifications-market-participants/significant-shareholders.html#/
It is the day after the Acer deal announcement.
Covid-19 variants looking like big trouble.. maybe they'll act and put therapeutics in the forefront.. the handling of this has to be the most foolish and insane thing I ever witnessed.. or maybe it's just greed and makes sense ??
Buying More !!
$RLF $RLFTF 0.47 CHF SWX: RLF +0.0080 (1.74%) Feb 1, 12:36
$APYP Snoring ..plenty of wives will see this as a safe alternative to murdering their husbands !!!
Our technology has been implemented for various uses by Boeing, General Motors, General Electric, Johnson & Johnson, Ford, Samsung and others.
I like this line most of all...shows the potential of this technology!!!
Nexense Technologies USA. Inc. is an American company with R&D center based in Israel that was established in 2001. Nexense developed an innovative sensor platform based on unique state of the art art international measuring technology. Our technology has been implemented for various uses by Boeing, General Motors, General Electric, Johnson & Johnson, Ford, Samsung and others.
Nexense has adapted and developed this unique, revolutionary sensor platform for use as a non-intrusive, wearable computer system, worn as a chest strap or wrist watch, for treating sleep apnea and snoring. Among the investors in the development of this product is General Electric.
These sleep disorders affect tens millions of people worldwide causing very poor quality sleep and consequent daytime fatigue and impaired alertness, as well as long-term damage such as liver disease and diabetes. Problems caused by sleep apnea and snoring include a shortage of oxygen to the brain, which can lead to heart attacks and strokes. An Israeli research from May. 2016 proved that 86% of patients that had strokes suffered from Sleep Apnea. Sleeping disorders also seriously disrupt the sleep of the sufferer’s partners.
Nexense Technologies
https://www.linkedin.com/in/nexense-clear-b601a4136
58 Million.. Looking GOOD !!